Creative Medical Technology Holdings (CELZ) Operating Margin Growth (1y) (2018 - 2025)
Analysis
Creative Medical Technology Holdings (CELZ) Operating Margin Growth (1y) (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.42 Bn | 112.79 Mn | 798.00 |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - | 2.46 Mn |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn | 13,751.00 |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 2,348.00 |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | -6,012.00 |
| 6 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - | -2.44 Mn |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 375,193.00 |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.36 Bn | 251.87 Mn | -1,560.00 |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 377.00 |
| 10 | Creative Medical Technology Holdings | 1.41 Mn | 1.41 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -200,160.00 |
| Dec 31, 2024 | -379,650.00 |
| Dec 31, 2023 | -2.53 Mn |
| Sep 30, 2023 | -2.39 Mn |
| Dec 31, 2022 | -3.16 Mn |
| Sep 30, 2022 | 647,905.00 |
| Dec 31, 2021 | -32,756.00 |
| Sep 30, 2021 | -801,946.00 |
| Jun 30, 2021 | -439,045.00 |
| Dec 31, 2020 | -935,947.00 |
| Sep 30, 2020 | 16,062.00 |
| Jun 30, 2020 | -32,080.00 |
| Mar 31, 2020 | -30,231.00 |
| Dec 31, 2019 | 806,954.00 |
| Sep 30, 2019 | 4,898.00 |
| Jun 30, 2019 | 611,179.00 |
| Mar 31, 2019 | 163,375.00 |
| Dec 31, 2018 | 456,822.00 |